Fmoc-L-leucinol

Fmoc-L-leucinol features an L-leucinol amino alcohol framework bearing a side chain consistent with leucine, with the primary amino group and carboxyl functionality incorporated into a protected derivative where the amino terminus is masked by an Fmoc (9H-fluoren-9-ylmethoxycarbonyl) group. The molecule therefore contains an Fmoc-protected amino moiety and a free hydroxymethyl alcohol at the leucinol position, while the carboxyl group is not present as a free acid in the name's implied amino alcohol structure. Fmoc-L-leucinol is used as a building block in peptide and amino-alcohol derivative synthesis, including solid-phase or solution-phase strategies where the Fmoc group supports stepwise assembly and the alcohol provides a handle for further functionalization or for incorporation into structure-activity and labeling studies.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.

CAT No: CP26360

CAS No:139551-83-0

Synonyms/Alias:FMOC-L-LEUCINOL;139551-83-0;(S)-(9H-Fluoren-9-yl)methyl(1-hydroxy-4-methylpentan-2-yl)carbamate;ZINC02560040;AmbotzFAL1080;CTK7J6999;MolPort-006-701-307;WXMGVJAOLIDKGZ-HNNXBMFYSA-N;ZINC2560040;ANW-61167;AKOS015909684;AJ-40430;AK-59053;KB-210540;RT-012995;FT-0697634;V2979;I14-32635;(S)-2-(9H-Fluorene-9-ylmethoxycarbonylamino)-4-methyl-1-pentanol

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C21H25NO3
M.W/Mr.
339.43

Fmoc-L-leucinol is an Fmoc-protected amino alcohol derived from L-leucine, featuring an Fmoc carbamate on the nitrogen and a primary alcohol on the side chain (leucinol motif) while retaining the stereogenic center of L-leucine. The molecule combines a protected amine functionality with a reactive hydroxyl group, enabling orthogonal chemistry in peptide and small-molecule synthesis. The Fmoc group supports base-labile deprotection under standard peptide-synthesis conditions, while the alcohol can be selectively esterified, etherified, or converted to leaving groups for downstream transformations. As a chiral amino acid derivative and peptide-compatible building block, Fmoc-L-leucinol functions as a handle for side-chain functionalization that preserves stereochemical information through coupling and subsequent derivatization.

1. Peptide Synthesis

Fmoc-L-leucinol serves as a peptide synthesis building block for constructing N-Fmoc-protected amino alcohol residues that can be incorporated into linear peptides and peptide fragments on solid support. The Fmoc carbamate enables controlled N-terminal activation and coupling, while the side-chain hydroxyl provides a functional group for in situ protection strategies or post-coupling derivatization. Orthogonal protection of the alcohol (for example, as an ether or ester) can be used to maintain compatibility with peptide coupling cycles and final deprotection logic. Resulting peptidic scaffolds can be used to probe how stereochemically defined amino alcohol side chains influence conformation, hydrogen-bonding patterns, and protease recognition in biochemical research workflows.

2. Side-Chain Functionalization

Fmoc-L-leucinol is suitable for amino acid derivatization and side-chain modification chemistry where the primary alcohol acts as a reactive pivot for generating hydroxyl-functional, ether-linked, or ester-linked analogs. The presence of the Fmoc-protected nitrogen allows selective manipulation of the alcohol without disrupting the protected amine during intermediate preparation. Conversion of the hydroxyl into protected or activated derivatives can support formation of C-O and C-C linkages, enabling attachment of solubilizing groups, affinity handles, or chemical probes after peptide assembly or during solution-phase synthesis. Downstream products derived from this chiral amino alcohol motif can serve as intermediates for peptidomimetics, structure-activity relationship studies, and fragment elaboration in synthetic organic chemistry.

3. Chemical Biology Probes

Fmoc-L-leucinol can be applied in chemical biology research for preparing stereodefined peptide analogs and conjugation-ready intermediates that incorporate an amino alcohol side chain. The alcohol functionality can be used to tune polarity and hydrogen-bond capacity, while the Fmoc-protected amine supports incorporation into labeled peptides or biomolecule-interacting sequences. Orthogonal derivatization of the hydroxyl enables installation of tags such as linkers for fluorophores, affinity reagents, or enrichment chemistries, supporting workflows for target engagement studies and binding-site mapping. Chiral preservation from the L-leucine stereocenter supports consistent structure-function relationships in molecular recognition experiments and biochemical assay development.

4. Process Chemistry Intermediate

Fmoc-L-leucinol functions as a chiral amino acid intermediate for fine chemical synthesis routes that require an Fmoc-protected nitrogen and a free primary alcohol for controlled downstream conversion. The orthogonal reactivity profile supports manufacturing-friendly protection/deprotection sequencing, where the Fmoc group can be removed without chemically destroying the alcohol when appropriate conditions are selected. The alcohol can be transformed into protected esters/ethers or activated intermediates to feed subsequent synthesis steps for peptide fragments, peptidomimetic cores, or specialty building blocks. Industrial relevance arises from its role as a chiral, stereochemically defined input that can be carried through multiple synthetic stages while maintaining compatibility with standard peptide coupling and protecting-group strategies.

5. Peptidomimetics And SAR

Fmoc-L-leucinol is suitable for peptidomimetic construction and SAR studies aimed at replacing or modifying natural amino acid side chains with amino alcohol functionalities. The Fmoc-protected amine supports incorporation into peptide-like backbones, while the side-chain hydroxyl enables systematic variation of hydrogen-bonding and steric effects through derivatization. Generated analog panels can be used to evaluate how stereochemically constrained amino alcohol substituents affect binding interactions, stability trends, and conformational preferences in target-focused screening programs. The compound's chiral amino acid derivative structure supports consistent scaffold generation for iterative medicinal chemistry and applied peptide science workflows.

Size
1 g;5 g;25 g;
InChI
1S/C21H25NO3/c1-14(2)11-15(12-23)22-21(24)25-13-20-18-9-5-3-7-16(18)17-8-4-6-10-19(17)20/h3-10,14-15,20,23H,11-13H2,1-2H3,(H,22,24)/t15-/m0/s1
InChI Key
WXMGVJAOLIDKGZ-HNNXBMFYSA-N
Canonical SMILES
CC(C)CC(CO)NC(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Peptide Nucleic Acids SynthesisPeptide CDMOEpitope Mapping ServicesPeptide Synthesis ServicesPeptide Analysis ServicesPeptide Modification ServicesCustom Conjugation ServicecGMP Peptide Service
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers